Pfizer and BioNTech accine is 97% Effective Against COVID 19

Pfizer and BioNTech Vaccine is 97% Effective Against COVID 19

The Pfizer and BioNTech candidate was shown to be 94.5% effective in clinical trials, but in the real world it has been shown to outperform even against newer variants.

Credit: Reuters/Amira Karaoud

The deployment of the vaccine in Israel shows that it is up to 97% effective against new infections and serious conditions of COVID-19.
Discover more stories at Business Insider Spain.

The Pfizer and BioNTech vaccine has proven to be 97% effective against new symptomatic infections of COVID-19, serious cases, and fatal risks, according to data from the Israeli Ministry of Health, reported by the pharmaceutical company.

The unvaccinated were 44 times more likely to suffer from symptomatic COVID-19 and 29 times more likely to die from an infection with the new coronavirus.

“The findings represent the most complete evidence in the real world to date, which demonstrates the effectiveness of a COVID-19 vaccine,” says Pfizer in the statement, which defends that the data also suggests that it prevents asymptomatic infection with SARS-CoV -2.

About Odutolu Timothy

Passionate about technology and communication, Timothy Odutolu has more than 5 years of experience writing for various niches in these fields. He's more comfortable writing about the key trends in the business-to-business software-as-a-service (B2B SaaS) niche. He is also a generalist with interests in journalism, DIY and outdoor, and other writing services. He's reachable via Twitter, LinkedIn, and email through or

Check Also

The Reality of Artificial Intelligence in Health

It is not possible to think about the future of health care without having two entiries which, together, represent the hopes and fears of an industry that is looking for smarter solutions. We're talking – how could it be otherwise – of artificial intelligence

Leave a Reply

%d bloggers like this: